What companies are NGEN.V's competitors?

NervGen Pharma Corp. (NGEN.V)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does NGEN.V compare to its peers?

The peer comparison table on this page shows NervGen Pharma Corp. (NGEN.V) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does NGEN.V operate in?

NervGen Pharma Corp. (NGEN.V) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

NGEN.V (NervGen Pharma Corp.) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

NGEN.V

NervGen Pharma Corp.

TSXV·Biotechnology · Healthcare

C$5.15C$0.15+3.00%

Market capC$407.94M·Mar 16 7:59 PM UTC

Frequently Asked Questions About NGEN.V

What companies are NGEN.V's competitors?: NervGen Pharma Corp. (NGEN.V)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does NGEN.V compare to its peers?: The peer comparison table on this page shows NervGen Pharma Corp. (NGEN.V) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does NGEN.V operate in?: NervGen Pharma Corp. (NGEN.V) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

NGEN.V (NervGen Pharma Corp.) is no longer actively trading.

NGEN.V

NervGen Pharma Corp.

TSXV·Biotechnology · Healthcare

C$5.15C$0.15+3.00%

Market capC$407.94M·Mar 16 7:59 PM UTC

Peers


FRX.TO	Fennec Pharmaceuticals Inc.	C$17.00	C$590.5M
CYBN.NE	Cybin Inc.	C$18.97	C$459.2M
EPRX.TO	Eupraxia Pharmaceuticals Inc.	C$10.21	C$366.9M
PRN.TO	Profound Medical Corp.	C$9.85	C$357.9M
XLY.TO	Auxly Cannabis Group Inc.	C$3.19	C$323.2M
DR.TO	Medical Facilities Corporation	C$15.59	C$273.6M
MSCL.TO	Satellos Bioscience Inc.	C$12.99	C$270.6M
HBP.TO	Helix BioPharma Corp.	C$1.95	C$148.9M
HLS.TO	HLS Therapeutics Inc.	C$3.68	C$115.1M
MDNA.TO	Medicenna Therapeutics Corp.	C$0.47	C$36.1M

Frequently Asked Questions About NGEN.V

What companies are NGEN.V's competitors?: NervGen Pharma Corp. (NGEN.V)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does NGEN.V compare to its peers?: The peer comparison table on this page shows NervGen Pharma Corp. (NGEN.V) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does NGEN.V operate in?: NervGen Pharma Corp. (NGEN.V) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.